EpiStack

O-38 - DEFUSE asserted its chimeric-spike work used bat-SARSr-CoV backbones and was 'exempt from dual use and gain of function concerns'

1 min read

Properties8
type
observation
id
O-38
statement
The proposal characterized its plan to insert novel spike proteins into WIV1/SHC014 bat-SARSr-CoV backbones as using bat backbones (not SARS-CoV) and therefore 'exempt from dual use and gain of function concerns' — the document's own risk framing.
link_state
linked
source
S-65 - Project DEFUSE proposal (EcoHealth Alliance to DARPA, 2018)
locator
Executive Summary — Technical Approach (TA1)
data_basis
quote
(these use bat-SARSr-CoV backbones, not SARS-CoV, and are exempt from dual use and gain of function concerns)

Documents the consortium’s own advocacy framing that the work fell outside gain-of-function/dual-use oversight — flagged in the source’s motivatedness as risk-minimizing advocacy rather than a neutral biosafety judgment. (Quote reconciled from degraded OCR of the scanned proposal.)

Graph View

Show model graphinteractive Bayesian view — separate from the graph above
added after the FLF submission deadline

Backlinks